Spinal Versus General Anesthesia on Postoperative Pulmonary Complications
Launched by TONGJI HOSPITAL · May 17, 2024
Trial Information
Current as of February 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two types of anesthesia—spinal anesthesia and general anesthesia—on patients who are having surgery for hip fractures. The main goal is to see if one type of anesthesia leads to fewer breathing problems after surgery compared to the other. The trial is currently looking for participants who are at least 65 years old, in relatively good health (classified as ASA Class I to III), and who need surgery for specific types of hip fractures that are not done urgently.
To join the study, participants should be able to walk a short distance without help before their fracture, and they should not have certain serious health conditions like heart failure or asthma. If you or someone you know meets these criteria and is interested in participating, they can expect to be part of a study that may help improve care for future patients undergoing hip surgery. The trial has a recruiting status, meaning they are actively looking for volunteers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 65 years old
- • ASA Class I \~ III
- • Surgical repair of femoral neck, intertrochanteric or subtrochanteric fractures
- • The time from diagnosis to surgery is more than 48 hours
- Exclusion Criteria:
- • Unable to walk about 3 meters or across a room without assistance before the fracture
- • Emergency surgery
- • Congestive heart failure, asthma, anemia (Hb \< 90 g/L), hypoalbuminemia (ALB \< 35g/L)
- • Abnormal coagulation function
- • Severe aortic stenosis
- • Injection site infection or increased intracranial pressure
- • Patients have participated in previous trials or have been determined by a surgeon or anesthesiologist to be unsuitable for randomization
- • The written informed consent of the patient or his/her representative cannot be obtained
Trial Officials
Tianzhu Liu, M.D.
Principal Investigator
Tongji Hospital
About Tongji Hospital
Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, is a leading medical institution in China dedicated to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary team of experts, Tongji Hospital focuses on translating scientific discoveries into effective treatments and therapies. The hospital is committed to enhancing patient care by conducting rigorous clinical trials that adhere to the highest ethical and regulatory standards, fostering collaboration with both national and international research communities to drive medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0